The latest market report published by Credence Research, Inc. “Global Colposcopes Market – Market Growth, Future Prospects, Competitive Analysis and Pipeline Analysis, 2017 – 2025,” the Colposcopes Market was valued at US$ 599.75 Mn in 2016, and is expected to reach US$ 964.44 Mn by 2025 expanding at a CAGR of 5.08 % from 2017 to 2025.
According to World Health Organization, approximately 500,000 cases of cervical cancer are diagnosed each year globally. Colposcopy is usually performed after the Papanicolaou (PAP) smear test. It is observed that demand for colposcopes have increased worldwide to prevent cervical cancer by detecting precancerous tissues, and it is also used to detect other gynecological disorders.
Browse the full report Global Colposcopes Market – Market Growth, Future Prospects, Competitive Analysis, and Pipeline Analysis 2017 – 2025 at http://www.credenceresearch.com/report/global-colposcopes-market
Optical colposcopes have been traditionally used by doctors to measure the size of the diseased region, they are comparatively less expensive than the electronic colposcope. The electronic colposcope on the other hand equipped with high definition imaging module and LED light source provides quality images and possess features like good mobility and advanced telemedicine solutions. Applications of colposcopy technique is the cervical disease diagnosis and physical examination of other gynecological disorders like cervical lesions, HPV infection etc.
The colposcopes market is technologically driven, associated devices of colposcopes have been upgraded to obtain high resolution 3D image, external micromanipulator to perform carbon dioxide laser therapy, straight or inclined binocular tubes, trolley or mounted devices and associated software have been installed for better interpretation of the diagnosis performed. The information can be archived for future reference purposes. leisegang, Olympus Corporation, Carl Zeiss Meditec AG, Koninklije N.V. are few market leaders in colposcope market who have technological advances in their colposcopy segment and compete to augment their foothold in the market.
Request Sample: http://www.credenceresearch.com/sample-request/58404
Key Market Movements:
Higher prevalence of cervical cancer and other gynecological disorders
Technological advances in colposcopy assessment
Government and non-government initiatives to fight cervical cancer and supporting reimbursement policies
Rising public awareness with early disease diagnosis
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith
Designation: Global Sales Manager
E-mail: [email protected]